American International Group’s 9 Meters Biopharma NMTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,620
Closed -$67K 3348
2022
Q1
$67K Sell
5,620
-396
-7% -$5.41K ﹤0.01% 2743
2021
Q4
$118K Sell
6,016
-98
-2% -$2.19K ﹤0.01% 2647
2021
Q3
$159K Buy
6,114
+160
+3% +$3.77K ﹤0.01% 2568
2021
Q2
$131 Buy
+5,954
New +$146K ﹤0.01% 2762
2019
Q2
Sell
-657
Closed -$25K 3176
2019
Q1
$25K Sell
657
-21
-3% -$908 ﹤0.01% 2980
2018
Q4
$31K Buy
678
+64
+10% +$4.74K ﹤0.01% 2980
2018
Q3
$84K Buy
614
+11
+2% +$1.89K ﹤0.01% 2919
2018
Q2
$284K Buy
+603
New +$222K ﹤0.01% 2164

Other funds holding NMTR

American International Group's NMTR Position: Q2 2022 in Review

American International Group sold out of 9 Meters Biopharma (NMTR) in Q2 2022, closing a stake of 5,620 shares — an estimated $67K sold.

American International Group first reported a position in NMTR in Q2 2018 and held it in 8 quarters. The position peaked at $284K in Q2 2018. 88 funds tracked by Wall St. Rank hold NMTR as of Q2 2022.

  • American International Group reported no remaining 9 Meters Biopharma position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 5,620 9 Meters Biopharma shares in Q2 2022, an estimated $67K.
  • American International Group first reported a position in 9 Meters Biopharma in Q2 2018 and held it in 8 quarters.
  • American International Group's 9 Meters Biopharma position peaked at $284K in Q2 2018.
  • 88 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.